Cargando…
What have we learned from immunotherapy? Report from the 3rd and 4th meetings of the Campania Society of Oncology Immunotherapy (SCITO)
Treatment strategies that target the immune system provide the opportunity for antitumor activity across multiple cancer types, regardless of mutational status or tumor histology. While many of the initial advances in immunotherapy have been in melanoma, the focus has now broadened to include many o...
Autores principales: | Ascierto, Paolo Antonio, Cartenì, Giacomo, Gridelli, Cesare, Pignata, Sandro, Pinto, Antonio, Criscitiello, Carmen, Buonaguro, Luigi, Pepe, Stefano, Mabilia, Roberto, Montesarchio, Vincenzo, Daniele, Bruno, De Placido, Sabino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950089/ http://dx.doi.org/10.1186/s40425-016-0144-y |
Ejemplares similares
-
The role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014
por: Ascierto, Paolo A, et al.
Publicado: (2014) -
The 2nd meeting of the Campania Society of Oncology Immunotherapy (SCITO): focus on hepatocellular carcinoma, kidney and bladder cancer
por: Daniele, Bruno, et al.
Publicado: (2016) -
Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Naples, Italy)
por: Ascierto, Paolo A., et al.
Publicado: (2019) -
Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, November 30th 2016
por: Ascierto, Paolo A., et al.
Publicado: (2017) -
Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)
por: Ascierto, Paolo A., et al.
Publicado: (2018)